Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve supply chain risks with this Pd-catalyzed one-pot synthesis. 3-iodochromone as cheap starting material, 110-130°C reaction, high yield. Ideal for API intermediates.
Solve 3-acyl pyrrole synthesis challenges with mild, green copper-catalyzed process. Achieve 60-70% yield, 50-80°C operation, and 99% purity for drug development. Request COA/MSDS now.
Solve supply chain risks with this metal-free 1,2,4-triazole synthesis. No anhydrous conditions, high yields (62-86%), and easy scale-up for pharma intermediates. Contact us for custom production.
Discover cost-effective, high-yield synthesis of indole-3-carboxamide for drug development. Reduce supply chain risks with scalable, one-step process. Contact us for custom manufacturing.
Discover high-purity axial chiral cyclopentenyl indole-naphthyl compounds with 99% ee for PC-3 cancer cell cytotoxicity. Optimize your drug development with scalable synthesis.
Solve 2,3-dihydroquinolone synthesis challenges with high-yield palladium-catalyzed carbonylation. Reduce costs and scale up for anti-cancer drug development.
Discover how visible light-induced, metal-free synthesis of 3-aryl-2H-indazoles reduces production costs and safety risks. Ideal for API manufacturing and drug development.
Discover a cost-effective, high-yield synthesis of 2-trifluoromethyl quinazolinones using iron catalysts. Ideal for pharmaceutical R&D and production scale-up with 74-93% yields.
Solve supply chain risks with this air-stable, room-temperature synthesis of trifluoromethyl pyrazoles. No heavy metals, no inert atmosphere needed. Scale to 100MT/yr.
Solve heavy metal contamination and low yield in oxazole synthesis. Our CDMO expertise delivers 90%+ purity with 4h reaction time. Scale to 100MT/yr.
Solve meloxicam production challenges with DMSO-based synthesis: 92% yield, 99.5% purity, and reduced toxic solvent use. Scale efficiently with CDMO expertise.
Efficient, scalable synthesis of 3-trifluoromethyl-1,2,4-triazole with 77-99% yields using molybdenum-copper co-catalysis. Reduce costs and supply chain risks for drug development.
Discover a scalable, high-yield method for 2-trifluoromethyl imidazoles with cheap starting materials. Reduce R&D costs and supply chain risks for your API synthesis.
Discover how axial chiral bisindole catalysts with >95:5 er enable scalable asymmetric synthesis, reducing R&D costs and supply chain risks for pharmaceutical intermediates.
Discover efficient, scalable synthesis of 3-trifluoromethyl 1,2,4-triazole compounds with >90% yields. Ideal for API manufacturing and drug development.
Solve low-yield issues in trifluoromethyl heterocycle synthesis. Our CDMO expertise scales this palladium-catalyzed method for high-purity API intermediates with 99%+ purity.
Discover a safe, high-yield synthesis for β-trifluoromethyl-2-methylene cyclopentanone. Reduce EHS risks and scale production with our CDMO expertise.
Discover a cost-effective, high-yield method for 2-trifluoromethyl imidazole synthesis. Our CDMO expertise ensures reliable supply for drug development and production.
Solve multi-step synthesis challenges with metal-free, high-yield imidazo[1,2-c]quinazolin-3(2H)-one production. Reduce costs and environmental risks for pharma supply chains.
Discover a novel benzindole synthesis method with 74-85% yield, no ligands, and green byproduct management. Reduce costs and environmental risks.